Deal Announcements

Ascent Therapeutics Secures $8 Million Series A

Monday, November 05, 2007 5:30:00 AM PDT | VentureDeal Staff

SHERBORN, MA -- Biotech company Ascent Therapeutics, Inc. has received $8 million in its first institutional round of venture capital funding, according to a report in PE Week Wire.

Ascent is focused on discovering and developing new therapies for cancer and inflammatory diseases.

Investors in the round included HealthCare Ventures, Novartis BioVenture Fund and TVM Capital.  Proceeds purposes from the funding were not disclosed by the company.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin

PCI - Level1